Free Trial

Maravai LifeSciences (MRVI) Competitors

Maravai LifeSciences logo
$2.43 -0.08 (-3.19%)
Closing price 04:00 PM Eastern
Extended Trading
$2.53 +0.10 (+4.07%)
As of 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MRVI vs. AMRX, CPRX, BHC, OGN, MIRM, XENE, IBRX, GMTX, ARWR, and APLS

Should you be buying Maravai LifeSciences stock or one of its competitors? The main competitors of Maravai LifeSciences include Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), Bausch Health Cos (BHC), Organon & Co. (OGN), Mirum Pharmaceuticals (MIRM), Xenon Pharmaceuticals (XENE), ImmunityBio (IBRX), Gemini Therapeutics (GMTX), Arrowhead Pharmaceuticals (ARWR), and Apellis Pharmaceuticals (APLS). These companies are all part of the "pharmaceutical products" industry.

Maravai LifeSciences vs. Its Competitors

Maravai LifeSciences (NASDAQ:MRVI) and AMNEAL PHARMACEUTICALS (NASDAQ:AMRX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

In the previous week, Maravai LifeSciences and Maravai LifeSciences both had 2 articles in the media. AMNEAL PHARMACEUTICALS's average media sentiment score of 1.42 beat Maravai LifeSciences' score of 1.05 indicating that AMNEAL PHARMACEUTICALS is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Maravai LifeSciences
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMNEAL PHARMACEUTICALS
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AMNEAL PHARMACEUTICALS has a net margin of -0.46% compared to Maravai LifeSciences' net margin of -67.14%. Maravai LifeSciences' return on equity of -12.91% beat AMNEAL PHARMACEUTICALS's return on equity.

Company Net Margins Return on Equity Return on Assets
Maravai LifeSciences-67.14% -12.91% -6.87%
AMNEAL PHARMACEUTICALS -0.46%-188.26%5.34%

Maravai LifeSciences currently has a consensus price target of $6.64, suggesting a potential upside of 173.21%. AMNEAL PHARMACEUTICALS has a consensus price target of $11.60, suggesting a potential upside of 45.55%. Given Maravai LifeSciences' higher possible upside, research analysts clearly believe Maravai LifeSciences is more favorable than AMNEAL PHARMACEUTICALS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maravai LifeSciences
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.25
AMNEAL PHARMACEUTICALS
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00

Maravai LifeSciences has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Comparatively, AMNEAL PHARMACEUTICALS has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

50.3% of Maravai LifeSciences shares are held by institutional investors. Comparatively, 31.8% of AMNEAL PHARMACEUTICALS shares are held by institutional investors. 2.1% of Maravai LifeSciences shares are held by company insiders. Comparatively, 26.6% of AMNEAL PHARMACEUTICALS shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

AMNEAL PHARMACEUTICALS has higher revenue and earnings than Maravai LifeSciences. AMNEAL PHARMACEUTICALS is trading at a lower price-to-earnings ratio than Maravai LifeSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Maravai LifeSciences$259.18M2.39-$144.85M-$1.14-2.13
AMNEAL PHARMACEUTICALS$2.79B0.89-$116.89M-$0.04-199.25

Summary

AMNEAL PHARMACEUTICALS beats Maravai LifeSciences on 11 of the 15 factors compared between the two stocks.

Get Maravai LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for MRVI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MRVI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MRVI vs. The Competition

MetricMaravai LifeSciencesMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$639.20M$10.25B$5.54B$9.41B
Dividend YieldN/A2.06%3.75%4.03%
P/E Ratio-2.1311.7121.0120.09
Price / Sales2.3930.03433.8199.01
Price / Cash4.0622.3936.1658.27
Price / Book1.073.578.125.65
Net Income-$144.85M$235.43M$3.25B$257.91M
7 Day Performance-10.99%-1.67%0.97%2.09%
1 Month Performance20.90%2.91%7.36%11.13%
1 Year Performance-73.00%-16.44%31.31%18.40%

Maravai LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MRVI
Maravai LifeSciences
3.5373 of 5 stars
$2.43
-3.2%
$6.64
+173.2%
-73.0%$639.20M$259.18M-2.13610Positive News
AMRX
Amneal Pharmaceuticals
3.2298 of 5 stars
$8.41
-0.1%
$11.60
+37.9%
+10.9%$2.64B$2.79B-210.208,100News Coverage
CPRX
Catalyst Pharmaceuticals
4.8975 of 5 stars
$20.95
-2.4%
$32.83
+56.7%
+26.9%$2.56B$491.73M13.3480Positive News
BHC
Bausch Health Cos
3.7223 of 5 stars
$6.88
-2.5%
$7.42
+7.8%
-14.9%$2.55B$9.63B-62.5520,700
OGN
Organon & Co.
4.8601 of 5 stars
$9.74
-2.2%
$18.00
+84.8%
-54.4%$2.53B$6.29B3.384,000Trending News
MIRM
Mirum Pharmaceuticals
3.7678 of 5 stars
$50.47
+0.3%
$65.50
+29.8%
+37.4%$2.50B$379.25M-31.35140News Coverage
XENE
Xenon Pharmaceuticals
3.4615 of 5 stars
$31.83
-4.3%
$54.82
+72.2%
-23.7%$2.44B$9.43M-9.85210Positive News
IBRX
ImmunityBio
2.2868 of 5 stars
$2.72
flat
$12.25
+350.4%
-53.8%$2.40B$31.22M-4.69590Gap Up
GMTX
Gemini Therapeutics
N/A$54.75
+3.0%
N/A+19.7%$2.37BN/A-54.7530
ARWR
Arrowhead Pharmaceuticals
3.8607 of 5 stars
$16.84
+0.3%
$43.71
+159.6%
-32.7%$2.33B$3.55M-12.03400News Coverage
Positive News
APLS
Apellis Pharmaceuticals
4.3305 of 5 stars
$17.42
-4.6%
$39.79
+128.4%
-49.3%$2.19B$781.37M-9.73770Trending News
Analyst Forecast
Insider Trade
Analyst Revision

Related Companies and Tools


This page (NASDAQ:MRVI) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners